Clinical Quality Measure
CMS135v2 (NQF 0081) - Additional Measure

Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Percentage of patients aged 18 years and older with a diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy.

NQS DOMAIN:   Clinical Process/Effectiveness




Description and Implementation within the EMR software

Denominator: All patients 18 years or older with at least 2 encounters during the meaningful-use reporting period and having one of the following ICD-10 codes selected in ASSESSMENT/DIAGNOSIS section on the ENCOUNTER form:
I11.0, I13.0, I13.2, I50.1, I50.20, I50.21, I50.22, I50.23, I50.30, I50.31, I50.32, I50.33, I50.40, I50.41, I50.42, I50.43, I50.9
AND who also have LVSD (LVEF < 40%)

Numerator: Patients in the above mentioned list to whom ACE inhibitor or ARB therapy such as Accupril, Diovan, Micardis, etc was prescribed. UniCharts looks for the custom code QM081A: [Quality Measure] HF patient with LVSD, ACE inhibitor or ARB therapy not prescribed or QM081B: [Quality Measure] HF patient with LVSD, ACE inhibitor or ARB therapy prescribed (4009F) or QM081C: [Quality Measure] HF patient with NO LVSD (LVEF within normal range) within the PROCEDURES/SERVICES section on the ENCOUNTER form as the required documentation.

Exceptions: UniCharts looks for the custom code QM081E: [Exception] Action specified in CMS135v2 not performed due to medical, patient, or system reasons within the PROCEDURES/SERVICES section on the ENCOUNTER form as the required documentation.

UniCharts Certified EMR software
UnisonCare Corporation 2003 - 2016. All Rights Reserved.